Genmab — Februar 2018

[E_L]

Clinical Trial: The MASTER Trial - https://www.myelomacrowd.org/clinical-trial-master/#comments - (on clinicaltrials since July17
https://clinicaltrials.gov/ct2/show/NCT03224507?term=dexamethasone+lenalidomide+daratumumab+and+carfilzomib&rank=2 )

[OHW]

Vi har desværre ofte den fejl her på siden og jeg selv også, at vi antager at folk handler rationelt...

[StockBull]

Nu var det jo en kanon guiding Jan kom med og han han gentage den 8 Maj med lidt ekstra guf mon saa ikke vi kan vinke farvel til de 1300. 1 line er nok ogsaa godkendt til den tid. Hvis markedet

[StockBull]

Kan han gentage

[StockBull]

Hvis markedet ellers arter sig de kommende maaneder. Beklager min iPad driller.

[E_L]

it is not unusual lately for price to drop in anticipation of warrant exercise

[Mcjean]

If Genmab have any mercy with stockholders they wait until friday after close:-)

[E_L]

if i look at this https://clinicaltrials.gov/archive/NCT02792218/2018_02_26/changes on the ASCLEPIOS I trial (Ofa/MS), wouldn't it be fair to say that Novartis is starting to get an idea of efficacy already?

[E_L]

they can't Mcjean, dates are set long time ago

[E_L]

by the way Celgene had a refusal by FDA on Ozanimod for MS, different sort of drug as Ofa, but still. https://www.businesswire.com/news/home/20180227006637/en/

[Bulder]

Do you know why all hospitals are called "Novartis Investigative Site". Haven't seen that before.

[Investor13]

Nogle der ved hvornår medarbejderne smider deres warrants i mark
kedet?

[Investor13]

markedet skulle der stå

[E_L]

No Bulder, don't know why they do that. If I am just guessing it might be a legal issue mentioning Novartis instead of the hospital name, an issue with rights or liability?

[Repsac]

HSBC kursmål er sikkert i USD.

[Parasitism]

Det ville næsten give mere mening

[peter12]

En ældre blogpost om Ofa http://multiple-sclerosis-research.blogspot.com/search?q=ofatumumab

[anncba]

Eller også er det kursmålet, når den er blevet splittet (O:

[pauly]

Anon samler op. Der ser ikke ud til det kursmål har særlig efftekt

[Teller]

Det er vel også kun de færreste der mener Genmab skal ned i kurs 1000, selv
på kort sigt.